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Abstract: Given the urgent informational needs connected with the pandemic 
diffusion of the Covid-19 infection, in this paper we propose a sample design to 
build up a continuous-time surveillance system. With respect to other 
observational strategies, the proposal has three important elements of strength 
and originality: (i) it not only aims at providing a snapshot of the phenomenon in 
a single moment of time, but it is designed to be a continuous survey, repeated in 
several waves through time, taking into account different target variables in 
different stages of the development of the epidemic; (ii) the statistical optimality 
properties of the proposed estimators are formally derived and tested with a 
Monte Carlo experiment and (iii) it is rapidly operational as it is required by the 
emergency connected with the diffusion of the virus. The sample design is thought 
having in mind, in particular, the SAR-CoV-2 diffusion in Italy during the Spring of 
2020. However, it is very general, and we are confident that it could be easily 
extended to other geographical areas and to possible future epidemic outbreaks. 
Formal proofs and a Monte Carlo exercise highlight the estimator is unbiased with 
a higher efficiency with respect to the simple random sampling scheme. 
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1. Background and purpose  
The worldwide urgent need to control the spread of SARS-CoV-2 requires an accurate 
evaluation of the sources of data on which the estimation of the epidemic’s main 
parameters can be based. Only in this way will we be able to monitor the evolution of the 
epidemic over time, supporting the decision makers in evaluating the effects of the 
restrictive measures gradually introduced and the time for their mitigation and removal. 
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In general, this is the way to produce possible future forecasts of the evolutions of the 
disease which are the essential basis for an effective healthcare response. Indeed, while 
some degree of uncertainty is inherent in any statistical modelling, the level of inaccuracy 
in monitoring the development of the situation can and must be kept under control.  
The objective of the proposed method is the definition of an observational protocol for 
observing the epidemic over time and providing statistically significant estimates of the 
size of the different components of the population identified concerning the SARS-CoV-2 
epidemy. Moreover, we aim to propose a dynamic monitoring tool that can be suitably 
calibrated both in the growth phase of the infections., and in the decreasing phase, with 
estimates extended to the parameters of the progressive immunization of the population. 
All estimates can be produced with associated reliability measures.  
Until now, however, with only few remarkable exceptions (see Section 2) data have been 
collected, favoring the examination of cases which display symptoms. This situation is 
described in statistics as “convenience sampling” in the presence of which no sound 
probabilistic inference is possible (Hansen et al., 1953). More precisely, while in a formal 
sample design the choice of observations is suggested by a precise mechanism based on 
the definition of inclusion probabilities of each unit (and, hence, by sound probabilistic 
inference), with a convenience collection no probability of inclusion can be calculated 
thus giving rise to over-under-representativeness of the sample units. 
In particular, several studies on Covid19 diffusion have clearly shown (e. g. Aguilar et al., 
2020; Chugthai et al., 2020; Li et al. , 2020; Mizumoto et al., 2020a, 2020b and Yelin et al., 
2020) that the available data strongly underestimate the number of infected people in 
that they are unable to capture, e. g., the asymptomatic cases with an obvious 
overestimation of the lethality rate6. On the other hand, a broad-based data collection of 
medical swabs carried out on a voluntary basis does not constitute a probabilistic sample 
either7. For instance, the practice of systematically collecting observations in the vicinity 
of supermarkets leads to an over-inclusion of healthy people in the sample, and to a 
systematic exclusion of those who (either because they are manifesting symptoms or in 
any case feel weak) have chosen to stay confined at home. 
However, it is of crucial importance for both government and health officials and for the 
population to have a clear understanding of the dynamics of the epidemics while it is in 
progress so that the government can take the appropriate measures and guide the 
individual behaviors. In such a situation, it is essential to set-up a system of data collection 
which can grant unbiased estimates and statistically significant comparisons through 
time and across different geographic areas.  
During the epidemic to be empirically relevant, not only any sample design has to be 
technically specified and the properties of the associated estimators have to be proved 
formally, but it has also to satisfy the following two conditions: 
• it has to be implemented as a surveillance system (or strictly related with the 
existing one) and repeated in several waves rather than to be a one-shot survey;  
• it has to be immediately operational considering the practical implications of data 
collection. 
 
6 Lethality rate is given by the proportion of death cases on the infected. 
7https://www.theguardian.com/world/2020/mar/30/immunity-passports-could-speed-up-return-to-work-
after-covid-19. 
3 
 
The latter point is particularly relevant in that the task may prove challenging especially 
in a situation where all the health operators are employed full time in the emergency 
operations related to the care of the more severe cases of infected people. 
 
Rather surprisingly the literature on the subject is still extremely poor. Few contributions 
have suggested the use of crowdsourced data rather than a sample design along with the 
officially collected data (Leung and Leung, 2020; Sun et al., 2020); the risk of erroneous 
inference based on them has been pointed out by Arbia (2020), Di Gennaro et al. (2020) 
and Ioannidis (2020). Our aim is to suggest a sample design whose statistical optimality 
properties are formally proved, that is also operational and can be immediately put into 
action taking into account the many practical obstacles that may arise in an emergency. 
Although we have in mind the Italian situation, we are rather confident that the suggested 
protocol could be easily extended to other countries. 
The rest of the paper is organized as follows. In Section 2 we present a review of the 
strategies and experiences in progress in the process of data collection until early April 
2020. In Section 3 we present the basic sampling framework of our suggested design by 
distinguishing two subsets of the population to be surveyed, namely those in which a state 
of infection has already been verified and those who were in contact with them (group A) 
and the healthy persons (group B). The different role of the two groups in monitoring the 
infections in different stages of the epidemic is also discussed. In Section 4 we focus on 
the parameters of interest that we aim at measuring with the suggested sample design on 
the two groups and we discuss how to disentangle possible overlaps between them whose 
presence may undermine the statistical properties of the estimations. In Section 5 we 
provide a general description of the sampling schemes for the two groups and the various 
operational options to be realized. In Section 6 we prove the unbiasedness of the 
estimates and derive the expression of the sampling variances. Section 7 is devoted to 
envisaging an extension of the proposed methodology to subsequent waves of data 
collection to monitor the phenomenon in different moments of time and stages of the 
epidemic. Section 8 contains some discussion on the efficiency of the estimators. Section 
9 illustrates the empirical results of a simulation study. Finally, in Section 10 we suggest 
some practical indications and future research priorities. The formal proofs are relegated 
to the Appendix. 
 
2.  The data collection of the epidemic: a review of strategies and experiences 
currently in progress  
In the emergency phase connected with the quick and uncontrolled diffusion of the Covid-
19, governments and institutions in charge are fully aware that knowledge and 
understanding of the dynamics in progress represent the central element for establishing 
how to intervene and in which geographical areas the intervention is more urgent.  
In reviewing the approaches followed by the different countries until early April 2020, we 
can identify four strategies and experiences in progress for the estimation of the 
phenomenon in the entire population. 
a) The first consists of massive test campaigns, regardless of the presence of symptoms, 
carried out without following a formal sampling design and essentially aimed at 
intervening in the outbreaks of the epidemic to identify subjects who are infected, but 
with no symptoms or only slight symptoms. This was the strategy of South Korea and 
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Hong Kong, as well of United Arab Emirates, Australia, Iceland, Veneto Region in Italy8. 
The big limit of this approach is the impossibility to make statistical inference of the 
results to the whole population.  
b) The second possible strategy consists in diagnostic tests through a probabilistic sample 
according to a planned design for the estimation of the phenomena of interest with 
predetermined precision levels, aimed at estimating the effective size of the infections, 
including the asymptomatic population. This is the case of the project by the Helmholtz 
Center for Research on Infections in Germany, based on blood testing for antibodies to the 
Covid-19 pathogen and involving over 100,000 individuals (Hackenbroch, 2020). 
Similarly, in Romania a random sample of 10,500 people living in Bucharest has been 
planned to detect the infected persons, following the directions of the Matei Bals Institute 
of Infectious Diseases in Bucharest (Romania-insider.com, 2020). Finally, a random 
selection of people who do not meet the testing criteria will be observed at two Canberra 
locations by the Australian Capital Territory (Abc, 2020). All these sample surveys are 
cross-sectional, useful to measure the infection in a precise instant. However, they have 
distinct characteristics from the continuous-panel-type surveys with a rotated sample for 
monitoring the evolution of the pandemic over time which constitutes the proposal of this 
paper.9 
c) The third strategy consists of a specific massive web-survey collected on individuals and 
households that decide to participate on a voluntary basis. Some 60,000 Israelis 
completed the online daily survey developed by the Weizmann Institute, disclosing 
personal details such as their age, gender, address, general state of health, isolation status 
and any symptoms they may be experiencing (Rossman et al., 2020). We observed 
examples of the same strategy in Iceland, Estonia and in other countries. The results allow 
to compare experiences of contagion and testing for people and households with different 
socio-economic characteristics. As for strategy a), the self-selection in the sample makes 
not possible to extend the results to the whole population. 
d) A further possible strategy is to use pre-existing sample surveys, partially modified in 
order to collect information on the epidemics. Creating an EU ‘Corona Panel’, as a 
standardised European sample tests to uncover the true spread of the coronavirus is, 
indeed, the proposal of the Centre for European Policy Studies, presented by Daniel Gros 
(2020). The proposal refers, in particular, to the use of the EU-wide sample of the panel 
of households which participate in the regular surveys on economic and social conditions, 
called ‘EU statistics on income and living conditions' (EU-SILC). More specifically, 
Dewatripont et al. (2020) suggest to implement two tests using the EU-SILC panel: the 
first aimed at assessing whether the subject is currently infected, and the second to test 
whether the person has become immune due to previous exposure.  
Timeliness is crucial. In this respect, the latter strategy seems to guarantee good results 
for the European Statistical System (ESS). A quick reflection could be made on the 
feasibility of inserting additional modules in the survey questionnaire of the quarterly 
Labour Force Survey (LFS), obviously in accordance with the Data Protection Authorities. 
 
8 France and Spain are still making tests only in the case of specific symptoms and contacts with infected 
people.  
 
9 UK and Italy recently realized sample surveys at national level to estimate the real prevalence rate of the 
infection (ONS, 2020; Istat, 2020). A critical review on the available data on Covid-19 and on the Italian 
sample survey project is contained in Alleva and Zuliani 2020, and Alleva, 2020. 
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The International Labour Organization (ILO) has reached out to the National Statistical 
Offices (NSOs) to understand the impacts of COVID-19 on their statistical operations, in 
particular in the domain of labour statistics (ILO, 2020). ILO recommended all countries 
to consider what additional information could be useful to capture the relevant aspects of 
the phenomenon. NSOs should consider if some existing topics are of lower priority, and 
thus can be temporarily removed from the surveys in order to create space for the new 
questions. 
Many countries are experiencing combinations of the previous different approaches to 
collect data on the epidemic as well integrating them with administrative data or other 
official statistical sources. While sample surveys represent a pillar to make inference to 
the whole population, planning and building integrated informative systems on the 
epidemic is certainly the right way for a deeper comprehension of the phenomenon. 
Finally, we observe that in this framework the new data sources (such as mobile phones, 
web-scraped data and internet-of-things data10 used bto trace the movements of people) 
should provide a useful contribution. 
 
3. The basic sample framework 
In what follows, we aim to propose an observational protocol for the estimation of the 
people infected by SARS-CoV-2 (Alleva et al., 2020). Starting from a population where it 
has been ascertained that individuals are infected (the verified cases), the aim is to 
estimate the population that is infected, but shows no symptoms (the asymptomatic 
cases). For the purpose of the proposed procedure, the individuals will be preliminarily 
classified into two sub-groups of interest which we will refer to as: group A and group B. 
Group A is the sub-group consisting of individuals for which a state of infection has been 
verified (who could be either hospitalized or in compulsory quarantine) and all the people 
who had contact with them in the previous days. Below we propose to observe the 
contacts till 14 days before the infection has been diagnosed, being this length in time the 
internationally accepted maximum incubation time. However, the unbiasedness of the 
sampling strategy we propose is still valid (even if less efficient) if the contacts are 
reconstructed for a shorter time period (e. g. 7 days). Therefore, this group contains all 
individuals who are foreseen to be infected and not only those for whom the infection has 
already been ascertained. They will represent, therefore, both the apparent and latent 
dimensions of the epidemic. 
Group B contains both healthy people for which the infection is considered latent and 
those who are still in a phase of incubation where the symptoms can become evident in a 
future moment of time, in the course of a maximum of 14 days. 
The rational for this breakdown of the population is related to the feasibility of the 
observational scheme which we propose. Indeed, the proportion of the infected people in 
the Group A is much larger than the one observed in Group B. Moreover, the number of 
verified infected people is known through the data collected by health public authorities. 
Thus, focusing the investments in observing the contacts of this group maximizes the 
number of infected people observed in the sample. Nevertheless, it is necessary to observe 
 
10 For example, data collection through images, useful for tracking movements of people or vehicles, or to 
detect gatherings in specific places. 
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the Group B so as to produce reliable estimate referred to the whole population, which is 
mandatory for correctly estimating the rate of infected people and the rate of lethality. 
Estimates relative to the two sub-groups may be obtained on the basis of a continuous 
observation in time and following two distinct methodologies, both based on what is 
known as indirect sampling, (Lavalle, 2007; Kiesl , 2016) the same technique  that is 
commonly used for estimation of rare and elusive populations (Sudman, 1988; Thompson 
and  Seber, 1996).  
It is important to underline that the distinctive element of our proposal lies in the estimate 
of the infected population obtained by combining together the results obtained through 
two samples drawn from the populations A and B, that can establish a different role in 
relation to the various development phases of the epidemics (in terms of sample size 
and/or type of diagnostic assessment to be carried out). 
At the beginning of the epidemics, the infection has the characteristics of rapidity, 
unpredictability of the level of spread, apparent concentration in certain geographical 
areas and categories of subjects. The response of the health system and the containment 
measures are not yet codified, as well as the responsible behaviour of the population. In 
this phase, an investigation strategy based on indirect sampling appears to be coherent, 
starting from the immediate surroundings of subjects that have a confirmed infection. 
This is the sampling strategy proposed for group A which, in addition to the estimation of 
a rare phenomenon in the population, provides also an immediate (and continuous over 
time) response to the epidemics where it explicitly manifests itself.  
On the other hand, in order to measure the intensity and the evolution of the phenomenon 
for larger territorial domains and in general with reference to relevant characteristics of 
people (gender, age, educational qualification, professional status and more), a traditional 
population panel survey with sample rotation aimed at group B can be carried out, 
associated with an indirect sampling mechanism in order to trace and to sample the 
individuals who came into contact with the infected people founded in this second sample. 
This panel survey becomes fundamental in the phases which follow the epidemic peak in 
order to measure not only the effective reduction of infections (and therefore to test the 
positive effects of the containment measures), but also the proportion of population that 
had contacts in the past with the virus. In the declining phase of the epidemics (which 
naturally does not exclude the resumption of infections in specific territories and 
environments), the role of the sample from the population group B is fundamental and 
representative of the entire population followed over time. On the other hand, also the 
diagnostic test must be identified taking into account the different importance that the 
infected population and the population susceptible to infection assume in the various 
phases of the epidemics. From an operational point of view, it seems convenient to rely 
on the nasopharyngeal swab for the sample of contacts in group A, regardless of the phase 
of the epidemics. For the panel survey, the serological examination may be more 
convenient, in particular in the declining phase, together with a part of the sample to be 
foreseen, to which the swab is also administered11.  
 
11 It is important to emphasize that, while the swab allows to estimate the infected population at a given moment 
of time, the serological test allows to estimate the population that had contact with the virus, without a time 
reference. On the other hand, both diagnostic tools provide answers affected by errors and consequently the 
estimates must be considered in probabilistic terms. In particular, in order to ensure greater reliability of the 
results, while for the swab the health protocols require its repetition through time so as to ascertain the healing 
of those who contracted the virus, for the serological examination, diagnostic kits can be considered that ensure 
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The combination of the two sampling strategies (with different weights in the ascending 
and descending phases of the epidemics) represents the competitive advantage of our 
proposal: a dynamic monitoring tool designed in order to be suitably calibrated both in 
the growth phase of the infections, providing estimates according to different categories 
of severity, and in the decrease phase, with estimates extended to the parameters of the 
progressive immunization of the population.  
The advantage over a strategy based exclusively on indirect sampling or only on the panel 
sample can be measured in terms of greater efficiency (and therefore accuracy of 
estimates), and lower investigation costs to achieve predetermined levels of precision. 
 
4. Specification of the total of infected people and its breakdown 
In what follows, let U be the population of interest of size N and denote with k (𝑘 =
1, … , 𝑁) a person belonging to it. Let 𝑣𝑘 be a dichotomous variable which assumes value 
1 if state of infection is verified and value 0 otherwise. Let 𝑈𝑣 = {𝑘 ∈ 𝑈: 𝑣𝑘 = 1} be the 
subpopulation of U of those for whom the infection is verified and let 𝑈𝐶 = 𝑈\𝑈𝑣 be the 
complementary subset.  
Let 𝑦𝑘 be the value for the person k of a variable 𝓎 which is equal to 1 if the person is 
infected and 0 otherwise. If 𝑣𝑘 = 1 then obviously it is also 𝑦𝑘 = 1, however if 𝑣𝑘 = 0, then 
it is possible that either 𝑦𝑘 = 1 (an infected person for whom the infection has not yet 
been verified) or 𝑦𝑘 = 0 (healthy person). 
The target parameter of our survey, Y , is the total of infected people (verified or not), that 
is: 
 
(1)   𝑌 = ∑ 𝑦𝑘
𝑘∈𝑈
. 
 
Let 𝑙𝑘,𝑗 be the generic entry of a link matrix (k=1,2,…,N; j=1, 2,…N) which is equal to 1 if 
the individual 𝑘 had contacts with individual j in the past 14 days and 0 otherwise, with 
𝑙𝑘,𝑘 = 1 by definition. Starting from 𝑈𝑣 , it is possible to determine the total of 𝓎 related 
to the group A,  
𝑈𝐴 = {𝑗 ∈ 𝑈: ∑ 𝑙𝑘,𝑗
𝑘∈𝑈𝑣
≥ 1} 
which includes the subset 𝑈𝑣 and all the contacts of those units. We express this formally 
as: 
 
(2)    𝑌𝐴 = ∑ ∑
1
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗 ,
𝑗∈𝑈𝑘∈𝑈𝑣
 
 
 
predetermined levels of specificity and sensitivity. For a discussion of the impact of these errors in epidemic 
stages characterized by a different base rate of infection, see Fuggetta (2020).  
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where 
 
(3)   𝐿𝑣𝑗 = ∑ 𝑙𝑘,𝑗
𝑘∈𝑈𝑣
 
 
is a quantity introduced in order to control the multiplicity of the measurement of the 𝑦𝑗 
among the different k units in 𝑈𝑣 in Equation 2. 
On the other hand, starting from 𝑈𝐶  it is possible to determine the total of 𝓎 related to the 
group B,  
𝑈𝐵 = {𝑗 ∈ 𝑈: ∑ 𝑙𝑘,𝑗
𝑘∈𝑈𝐶
≥ 1} 
which includes 𝑈𝐶  and all the contacts of the infected people of 𝑈𝐶: 
 
(4)    𝑌𝐵 = ∑ 𝑦𝑘 ∑
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗 ,
𝑗∈𝑈𝑘∈𝑈𝐶
 
 
where, analogously to Equation (3), the quantity: 
 
(5)   𝐿𝐶𝑗 = ∑ 𝑦𝑘  𝑙𝑘,𝑗
𝑘∈𝑈𝐶
 
 
is introduced in order to control for the multiplicity of the measurement of the 𝑦𝑗 in (4) 
among the different k units in 𝑈𝐶 . 
The set 𝑈𝐴 and 𝑈𝐵 can obviously overlap. Let us define their intersection as the set 
𝑈𝐴𝐵 = 𝑈𝐴 ∩ 𝑈𝐵 = {𝑗 ∈ 𝑈: 𝐿𝑣𝑗𝐿𝐶𝑗 ≥ 1 }. 
The total of the 𝓎 in 𝑈𝐴 ∩ 𝑈𝐵 is given by: 
(6) 𝑌𝐴𝐵 = ∑ 𝑦𝑗
𝑗∈𝑈:𝐿𝑣𝑗𝐿𝐶𝑗 ≥1
   
We may obtain alternative expressions of 𝑌𝐴𝐵 starting from the sampling frames 𝑈𝑣 and 
𝑈𝐶  
(7𝑎) 𝑌𝐴𝐵 = ∑ ∑
1
𝐿𝑣𝑗
𝑙𝑘,𝑗
𝑗∈𝑈𝑘∈𝑈𝑣
𝑦𝑗𝕀(𝐿𝐶𝑗 ≥ 1), 
(7𝑏) 𝑌𝐴𝐵 = ∑ 𝑦𝑘 ∑
1
𝐿𝐶𝑗
𝑙𝑘,𝑗
𝑗∈𝑈𝑘∈𝑈𝐶
𝑦𝑗𝕀(𝐿𝑣𝑗 ≥ 1) 
where 𝕀(𝐴) equals 1 if A is true and 0 otherwise. The expressions (7a) and (7.b) are 
useful in the estimation phase, as illustrated in section 6.3. 
Finally, we have  
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(8)    𝑌 = 𝑌𝐴 + 𝑌𝐵 − 𝑌𝐴𝐵. 
The above set-up is illustrated in the Figure 1 below. 
 
Figure 1.  Population of interest and its breakdown among the different groups 
 
 
 
5. The sampling design 
5.1. General description of the sampling schemas 
Two independent samples, namely 𝑆𝑣 and 𝑆𝐶 , are selected by the two population subsets,  
𝑈𝑣 and 𝑈𝐶  which represent the sampling frames. The contacts of infected people in each 
sample are tracked. The first sample 𝑆𝑣 is used for producing an unbiased estimate of 𝑌𝐴, 
while 𝑆𝐶  is used for estimating the total 𝑌𝐵. The total 𝑌𝐴𝐵 is estimated from the both 
samples. 
 
5.2. Sampling from 𝑈𝑣 
The subset of the verified infected increases over time. It is therefore necessary to set-up 
a sampling mechanism which is realized continuously over time. In order to simplify the 
sampling description, let us suppose that 𝑈𝑣 represents the set of the verified infected 
people in a given time period. The sampling from 𝑈𝑣 is carried out in the following phases: 
a) a sample 𝑆𝑣 is selected without replacement  from 𝑈𝑣  with inclusion probabilities 
𝜋𝑣𝑘  (𝑘 = 1,2 … , #𝑈𝑣). 
b) All the contacts 𝑈𝑘 = {𝑗 ∈ 𝑈: 𝑙𝑘,𝑗 = 1} of the individual k selected in 𝑆𝑣 are tracked 
going back 14 days.  
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c) A sample 𝑆𝑣𝑘  is selected from 𝑈𝑘  without replacement and with equal probabilities 
of inclusion 𝜋2𝑣|𝑘 . We use 2 in 𝜋2𝑣|𝑘 for indicating that this is the inclusion 
probability of the second stage of the sampling, given the selection of unit k in the 
first stage. 
At the end of the above process, the sample 𝑆𝐴 = 𝑆𝑣 ⋃ 𝑆𝑣𝑘
#𝑆𝑣
𝑘=1  is formed with a sampling 
indirect mechanism including people from both 𝑆𝑣 (verified infected people) and ⋃ 𝑆𝑣𝑘
#𝑆𝑣
𝑘=1  
(tracked contacts going back 14 days). 
The test to verify the infection is carried out on all the tracked contacts, ⋃ 𝑆𝑣𝑘
#𝑆𝑣
𝑘=1  . Thus, 
the value of 𝓎 is known for all the people in 𝑆𝐴. 
Remark 1.  The phase of tracking all the contacts of a person could be complex and 
cumbersome. Different solutions are possible. One possibility is to leverage from digital 
apps allowing epidemic control with digital contact tracing as suggested by Ferretti et al. 
(2020). Similarly, Ascani (2020) suggests a method based on personal interview. In this 
case the interviewees must be guided in remembering their contacts by means of a 
specific structure based on the reconstruction of the "social networks" contacted in the 
days preceding the infection (Scott, 2000 and Yang et al., 2016). 
Remark 2.  It is clear that for health and wellbeing reasons and to prevent the spread of 
the infection, it would be best to examine all infected people. However, from the statistical 
point of view, to obtain estimates of high quality regarding the number of infected 
persons, this is not strictly necessary. From this point of view, it is more important to 
concentrate the effort in repeating the examination regularly in time. This effort would be 
unsustainable with a complete study on the whole population. 
5.2.1. Definition of the sampling design  
The sampling mechanism for selecting 𝑆𝑣 depends on how the data frames for 𝑈𝑣 are 
organized. There are two main possibilities: 
Option 1.  The data of 𝑈𝑣 are available in a centralized data set which can be used for the 
sample selection, 
Option 2.  The data of 𝑈𝑣 are available only at a decentralized level, so that each 
healthcare institution has its own list. 
The two available options will be discussed in turn in the next two sub-sections. 
5.2.1.1 Sampling mechanism for Option 1 
If the sampling frame of the infected people is centralized in a unified dataset, one could 
define a one stage sampling design selecting directly the sample units from it. The 
sampling selection can be carried out with the cube algorithm (Deville and Tillé, 2004, 
2005), thus ensuring that the Narain Hortvitz-Tompson estimates (Narain, 1951; Horvitz 
and Thompson, 1952) of the selected sample reproduce the known totals of some 
auxiliary variables (e.g. distribution by sex and age, employment status, geographical 
distribution etc.This can be expressed as follows: 
 
(9)    ∑
𝐱𝑘
𝜋𝑣𝑘𝑘∈𝑆𝑣
= ∑ 𝐱𝑘
𝑘∈𝑈𝑣
, 
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where 𝐱𝑘 is a vector of P auxiliary variables available for the unit k . 
The definition of the optimal inclusion probabilities 𝜋𝑣𝑘  for the indirect sampling which 
minimize the cost ensuring a pre-defined level of accuracy for the sampling estimates (or, 
inversely, minimizing the sampling variances for a given budget) can be determined as 
illustrated by Falorsi and Righi (2019). Tillé and Wilhelm (2017) suggest to select the 
sample satisfying Equation (9) through a balanced spatial sampling algorithm which is 
somehow optimal in maximizing the entropy and minimizing the spatial correlation 
between neighbouring units (Arbia, 1994; Arbia and Lafratta, 1997, 2002). 
Falorsi and Righi (2015) demonstrate that the balancing equations (9) are quite general 
and allow the definition of a wide class of sampling designs which includes, among the 
others the Simple Random Sampling Without Replacement (SRSWOR), the Stratified 
Random Sampling Without Replacement (STSRSWOR), the Stratified random sample 
with probability proportional to size (PPS), the sample designs with incomplete 
stratification (SDIS) and many others. 
Assuming an SRS design, in order to obtain statistical estimates of the number of infected 
persons in a given spatial (the whole national territory or specific geographic area such 
as, for example, a region) and temporal domain (week/day), it would be sufficient to 
select about 1,000 individuals to test among the contacts of the infected set of persons. 
This sample size would ensure a reliable estimate with a sampling error around 5% under 
the assumption that the proportion of infected people in the target population is roughly 
around 25%. 
5.2.1.2. Sampling mechanism for Option 2 
If the sampling frames for 𝑈𝑣 are available only at healthcare institution level, the 
selection of units in 𝑆𝑣 can be carried out with a two-stage mechanism: 
1. First stage. A sample 𝑆1𝑣 of health care institutions is selected from the population 
of health care institutions (call it 𝑈1𝑣). The first stage sample is selected without 
replacement and with Probability Proportional to Size, where the healthcare institution i 
is selected with inclusion probability given by: 
(9)   𝜋1𝑖 = 𝑚
𝑀𝑖
𝑀
, 
in which m is the selected number of healthcare institutions to be included in the first 
stage sampling,  𝑀𝑖 is a measure of size of unit i and M is the overall measure of size. We 
may define the measure of the size according to different criteria. A good option would be 
the number of beds available for SARS-CoV-2 patients. The sampling selection of the 
health care institutions can be carried out with the already quoted “cube algorithm”, thus 
ensuring that the Narain Hortvitz-Tompson estimates of the selected first stage sample 
reproduce the known characteristics of some auxiliary variables available for the 
Population 𝑈1𝑣 (e. g. geographical distribution, number of beds available for SARS-CoV-2 
patients etc.). This can be expressed as: 
 
(10)    ∑
𝐱1𝑣
𝜋1𝑣𝑖∈𝑆1𝑣
= ∑ 𝐱𝑘
𝑘∈𝑈1𝑣
, 
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where 𝐱1𝑣 is a vector of auxiliary variables for the unit k. As suggested for option 1, the 
sample could be selected, respecting the equation (10), with a balanced spatial sampling 
algorithm which is optimal, maximizing the entropy and minimizing the spatial 
correlation of the neighbouring units. Even in this case, the balancing equations (10) 
allow to define the general class of sampling designs described in Falorsi and Righi 
(2015). 
2.  Second stage. A fixed number, say ?̅?, of infected people is selected in the sampled 
institution drawing the unit without replacement with a simple random sampling 
procedure.  
In such a way, the sampling is self-weighting (Murthy and Sethy, 1965) in the sense that 
all the units in 𝑈𝑣 have an equal probability to be selected. Indeed, the final inclusion 
probability of the person k to be selected in the healthcare institution i is given by the 
following expression: 
 
(11)    𝜋𝑣𝑘 = 𝑚
𝑀𝑖
𝑀
?̅?
𝑀𝑖
= 𝑚
?̅?
𝑀
. 
 
The self-weighting property defines a sampling design which is somehow optimal (Kish, 
1966) in the sense that it avoids the negative impact on the sampling variances due to the 
variability of the sampling weights. 
 The sampling selection criterion could be based on a time mechanism, which is feasible 
and, at the same time, easily implementable at a decentralized level. For instance, a sample 
of infected people could be selected considering those who had access to the healthcare 
institution within a window of a two-hour time period. 
 
5.3. Sampling from 𝑈𝐶  
In this section, we illustrate the sampling design for the first-time occasion in which we 
select, independently from 𝑆𝑣, a panel of individuals for estimating the total 𝑌𝐵 . 
Afterwards, we will monitor these people repeatedly over time. 
The operational aspects to be carried out in this first-time occasion are: 
a) First of all, a sample 𝑆𝐶  is selected without replacement  from 𝑈𝐶  with inclusion 
probabilities 𝜋𝐶𝑘  (𝑘 = 1,2 … , #𝑈𝐶). 
b) The people in the panel make to a diagnostic test on a regular basis (for example, once 
a month). If the member k of the panel receives a positive test result (i. e. 𝑦𝑘 = 1), all 
their contacts 𝑈𝑘  are tracked, going 14 days back in time.  
c) If 𝑦𝑘 = 1, a sample 𝑆𝐶𝑘 is selected from 𝑈𝑘  without replacement and with equal 
inclusion probability 𝜋2𝐶|𝑘 . We adopted for the second stage inclusion probability, 
𝜋2𝐶|𝑘 , the same notation used for 𝜋2𝑣|𝑘. At end of the whole process, the sample 𝑆𝐵 =
𝑆𝐶 ⋃ 𝑆𝐶𝑘
#𝑆𝐶
𝑘=1:𝑦𝑘=1
 is formed with an indirect sampling mechanism including people 
from both 𝑆𝐶  (people for which the infection status is not known) and ⋃ 𝑆𝐶𝑘
#𝑆𝐶
𝑘=1:𝑦𝑘=1
 
(tracked contacts going back 14 days of the infected people in 𝑆𝐶). 
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Remark 3. The populations 𝑈𝑣 and 𝑈𝐶  change as a function of time. The panel can be 
representative of the shifting population. We discuss this topic later on in section 7. Here, 
we note that in the subsequent survey occasions, the verified infected people of the panel 
are automatically captured by the sampling mechanism defined for the population 𝑈𝑣. 
While, the sample 𝑆𝐶  reduces its size, observing only the non-verified infected people. 
This reduction of the sampling size makes it necessary a regular refresh of the panel over 
time. 
5.3.1. A note on some practicalities of the sampling design 
The sampling design of the panel could be carried out according to different schemas, 
depending on the availability of the frame and on other organizational aspects. One 
possibility is that to form a sub-sample of a regular survey on households carried out by 
official statistics. Here we assume that the frame on U is represented by a register which 
is available at a central level, and that for each sample unit we avail a set of auxiliary 
variables. We assume, furthermore, that in this register the subset 𝑈𝐶  could also be 
identified. 
In this informative contexts, one stage sampling design could be carried out with optimal 
inclusion probabilities 𝜋𝐶𝑘 determined following Falorsi and Righi (2015, 2019). The 
sample selection could then be carried out with a balanced spatial sampling algorithm 
(Tillé and Wilhelm, 2017) ensuring the respect of the following balancing equations: 
 
(12)    ∑
𝐱𝑘
𝜋𝐶𝑘𝑘∈𝑆𝐶
= ∑ 𝐱𝑘
𝑘∈𝑆𝐶
. 
 
Remark 4. The panel could be constructed using a two-phase design so as to be able to 
select by using pre-screening, two sub-groups, namely:  
- a number of individuals who continue to travel (and are therefore more subject to 
being infected 
- a number of individuals with few contacts who fully observe the prescribed 
quarantine recommendations. 
Remark 5. The two-phase mechanism could be useful if the identification of 𝑈𝐶  could not 
carried out. This could be realized in the two-pre-screening phase. 
The number of persons involved in the panel may be about 1,000 (to obtain around 1,200 
tested individuals) for a given territorial and temporal sampling domain, thus 
guaranteeing a reliable estimation with a sampling error roughly around 10% assuming 
that the proportion of infected people in this target population is around 10%.  
 
5.4. Final comments on the sampling design 
We first note that in our proposal we sub-sample from the list of contacts. We adopt this 
choice for controlling the survey costs. However, we could extend the sample on all the 
set of contacts. Furthermore, if we continue the tracking on the contacts till all the people 
tracked is not infected, the sample design adopted becomes a classic adaptive schema 
(Thompson and Seeber, 1996), which can thus be seen as a particular application of our 
proposal. 
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Comments and good suggestions in this respect came from a discussion with the 
Portuguese National Statistical Office (INE) and in particular from Francisco Lima, 
President, Pedro Campos, Director of the Methodology Department and João Lopes from 
the same department., with some contributions from Portuguese academia. 
Given the complexity of the epidemiology of Covid-19, it may be useful to consider sub-
groups in Group B. This may become useful in the need of considering heterogeneous 
models (i. e. considering heterogeneous populations) as it seems to be required for the 
infectious agent. In particular, it may be important to consider breaking down certain 
epidemiological parameters into different sub-groups (e. g. transmission coefficient, time 
to become infectious, proportion of detected cases, time to detection, time to recover). 
Therefore, we suggest to define 4 subgroups considering both the binary factor low-
risk/high-risk and the binary factor low-mobility/high-mobility. These are the following: 
- a number of individuals not belonging to high-risk groups who continue to 
travel/work (and are therefore more subject to being infected and infectious); 
- a number of people not belonging to high-risk groups with few contacts who fully 
observe the prescribed quarantine recommendations; 
- a number of individuals belonging to high-risk groups who continue to 
travel/work (and are therefore more subject to being infected and infectious), 
such as health-care workers; 
- a number of people belonging to high-risk groups with few contacts who fully 
observe the prescribed quarantine recommendations. 
As for Group A, there might be some advantage in consider the same 4 sub-groups, since 
the transmission coefficient of each of these sub-groups can be significantly different. 
Considering 4 sub-groups in both Group A and B may impact on the sample size which is 
required to obtain a given sampling error at the sub-group level. The Group B has the 
potential of studying in detail some crucial "invisible" parameters of the epidemiology of 
Covid-19 (e. g. proportion of asymptomatic cases, time for symptomatic and 
asymptomatic to become infectious, and even the proportion of undetected symptomatic 
cases) and for each of the 4 subgroups independently. Its sample size should be defined 
with this in mind. The population density is also an important factor to control in the 
phase of sampling design. 
 
6. Sample estimation of the total of infected people 
We can compute a direct estimation of the total Y for each time and each territorial unit, 
as: 
 
(13)    ?̂? = ?̂?𝐴 + ?̂?𝐵 − ?̂?𝐴𝐵, 
being 
(14)    ?̂?𝐴𝐵 =  𝛼?̂?𝐴𝐵
𝐴 + (1 − 𝛼)?̂?𝐴𝐵
𝐵 , 
 
where ?̂?𝐴 and ?̂?𝐴𝐵
𝐴  are the Generalized Weight Share Method (GWSM, Lavallé, 2007) 
estimates of the totals 𝑌𝐴 and 𝑌𝐴𝐵 derived from the sample 𝑆𝐴;  ?̂?𝐵 and ?̂?𝐴𝐵
𝐵  are the GWSM 
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estimates of the totals 𝑌𝐵 and 𝑌𝐴𝐵 calculated from the sample 𝑆𝐵 and ?̂?𝐴𝐵 is a convex 
combination of the GWSM estimates ?̂?𝐴𝐵
𝐴  and ?̂?𝐴𝐵
𝐵 , being 0 ≤ 𝛼 ≤ 1. 
6.1. Estimation of the component ?̂?𝐴  
The GWSM estimator of the total number of infected people in group A, as expressed in 
Equation (2), is given by 
 
(15)    ?̂?𝐴 = ∑
1
𝜋𝑣𝑘  
∑
1
𝜋2𝑣|𝑘
1
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑆𝑣𝑘𝑘∈𝑆𝑣
 
= ∑
1
𝜋𝑣𝑘  
?̂?𝑣𝑘
𝑘∈𝑆𝑣
, 
 
where: 
 
(16)     ?̂?𝑣𝑘 = ∑
1
𝜋2𝑣|𝑘
1
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑆𝑣𝑘
 
 
represents the second stage estimate of  
 
(17)     𝑍𝑣𝑘 = ∑
1
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗 .
𝑗∈𝑈𝑘
 
 
Remark 6. the term 𝐿𝑣𝑗 in the previous equation corresponds to the total number of 
contacts of the unit j with the verified infected people. It can be collected either with 
digital contact tracing (Ferretti, 2020) or by the interviews.  
Proof of the unbiasedness of  ?̂?𝐴 
This proof can be found in section 5.1 of Lavallée (2007). Denoting with 𝐸(∙) the operator 
of sampling expectation, we have  
 
(18)   𝐸(?̂?𝐴) = 𝐸 [∑ ∑
𝛿𝑣𝑘
𝜋𝑣𝑘𝜋2𝑣|𝑘
 𝛿2𝑣𝑗|𝑘
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑈𝑘∈𝑈𝑣
], 
 
where: 𝛿𝑣𝑘 is a dichotomous variable being 𝛿𝑣𝑘 = 1 , if 𝑘 ∈ 𝑆𝑣 and 𝛿𝑣𝑘 =0, otherwise; and 
𝛿2𝑣𝑗|𝑘  is a second dichotomous variable being  𝛿2𝑣𝑗|𝑘 = 1 , if 𝑗 ∈ 𝑆𝑣𝑘  and 0, otherwise.  
From Equation (18) we obtain: 
 
(19)    𝐸(?̂?𝐴) = ∑ ∑
𝐸(𝛿𝑣𝑘𝛿2𝑣𝑗|𝑘)
𝜋𝑣𝑘𝜋2𝑣|𝑘
 1
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑈𝑘∈𝑈𝑣
. 
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However, since: 
 
(20)  𝐸(𝛿𝑣𝑘𝛿2𝑣𝑗|𝑘) = 𝐸[𝛿𝑣𝑘𝐸(𝛿2𝑣𝑗|𝑘|𝛿𝑣𝑘 = 1)] = 𝐸[𝛿𝑣𝑘𝜋2𝑣|𝑘] = 𝜋𝑣𝑘𝜋2𝑣|𝑘 , 
 
plugging the expression (20) into equation (19), we finally have: 
 
𝐸(?̂?𝐴) = ∑ ∑
 1
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗 = 𝑌𝐴.
𝑗∈𝑈𝑘∈𝑈𝑣
                                                                          Q. E. D. 
Variance of   ?̂?𝐴 
The main results on this topic can also be found in section 5.1 of Lavallée (2007). On the 
basis of the theorem on two stage sampling (Cochran, 1977), the variance of ?̂?𝐴 can be 
expressed as follows: 
 
(21)   𝑉(?̂?𝐴) = 𝑉1 (∑
1
𝜋𝑣𝑘  
𝑍𝑣𝑘
𝑘∈𝑆𝑣
) + ∑
1
𝜋𝑣𝑘  
𝑉2
𝑘∈𝑈𝑣
(∑
1
𝜋2𝑣|𝑘
1
𝐿𝑣𝑗
 𝑙𝑘,𝑗𝑦𝑗 ,
𝑗∈𝑆𝑣𝑘
). 
In the previous expression the variance is decomposed into the sum of the first stage 
variance (𝑉1) and the first stage expectation of the second stage variance (𝑉2). All the 
elements of the previous expression can be estimated with standard statistical inferential 
techniques (see Horvitz and Thompson, 1952 and Kish, 1965). 
 
6.2. Estimation of the component ?̂?𝐵 
The GWSM estimator of the component ?̂?𝐵is given by: 
 
(22) ?̂?𝐵 = ∑
1
𝜋𝐶𝑘  
𝑦𝑘 ∑
1
𝜋2𝐶|𝑘
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑆𝐶𝑘𝑘∈𝑆𝐶
 
                = ∑
1
𝜋𝐶𝑘  
?̂?𝐶𝑘
𝑘∈𝑆𝐶
 
 
where the term: 
 
(23)    ?̂?𝐶𝑘 = 𝑦𝑘 ∑
1
𝜋2𝐶|𝑘
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗 ,
𝑗∈𝑆𝐶𝑘
 
 
represents the estimate of  
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(24)    𝑍𝐶𝑘 = 𝑦𝑘 ∑
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗 .
𝑗∈𝑈𝑘
 
Proof of the unbiasedness of  ?̂?𝐵 
To prove the unbiasedness, first of all we have:  
 
(25)    𝐸(?̂?𝐵) = ∑ 𝑦𝑘 ∑
𝐸(𝛿𝐶𝑘  𝛿2𝐶𝑗|𝑘)
𝜋𝐶𝑘  𝜋2𝐶|𝑘
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑈𝑘𝑘∈𝑈𝐶
, 
 
where 𝛿𝐶𝑘 is a dichotomous variable being  𝛿𝐶𝑘 = 1 , if 𝑘 ∈ 𝑆𝐶  and 𝛿𝐶𝑘 =0, otherwise; and 
𝛿2𝐶𝑗|𝑘 is a dichotomous variable being 𝛿2𝐶𝑗|𝑘  = 1 , if 𝑦𝑘 = 1 ∩ 𝑗 ∈ 𝑆𝐶𝑘  and 0, otherwise.  
However, we have: 
 
(26)  𝐸(𝛿𝐶𝑘 𝛿2𝐶𝑗|𝑘) = 𝐸[𝛿𝐶𝑘𝐸(𝛿2𝐶𝑗|𝑘|𝛿𝐶𝑘 = 1)] = 𝐸[𝛿𝐶𝑘𝜋2𝐶|𝑘] = 𝜋𝐶𝑘  𝜋2𝐶|𝑘 . 
 
From Equation (25) and (26) it follows: 
 
𝐸(?̂?𝐵) = ∑ 𝑦𝑘 ∑
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑈𝑘∈𝑈𝐶
.                                                                            Q. E. D. 
 
The term 𝐿𝐶𝑗 corresponds to the total number of contacts of the unit j with not verified 
infected people. Similarly, to what happens for the estimation of ?̂?𝐵 𝑡his information can 
be collected either with digital contact tracing or by the interview. Alternatively, we could 
determine it by following a back-tracing process: if the unit j is infected, we should test 
the infection of Covid-19 on all their contacts. 
Variance of  ?̂?𝐵  
The variance may be obtained by simply adapting the expression (21), being:   
(27)   𝑉(?̂?𝐵) = 𝑉1 (∑
1
𝜋𝐶𝑘  
𝑍𝐶𝑘
𝑘∈𝑆𝐶
) + ∑
1
𝜋𝐶𝑘  
𝑉2
𝑘∈𝑈𝐶
(𝑦𝑘 ∑
1
𝜋2𝐶|𝑘
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑆𝐶𝑘
). 
6.3. Estimation of the component ?̂?𝐴𝐵 
Starting from the expression (7a), we obtain the GWSM unbiased estimator of 𝑌𝐴𝐵 with 
the data of the sample 𝑆𝐴, as  
(28) ?̂?𝐴𝐵
𝐴 = ∑
1
𝜋𝑣𝑘  
∑
1
𝜋2𝑣|𝑘
1
𝐿𝑣𝑗
𝑙𝑘,𝑗
𝑗 ∈𝑆𝑣𝑘𝑘∈𝑆𝑣
𝑦𝑗𝕀(𝐿𝐶𝑗 ≥ 1). 
Starting from the expression (7b), we derive the GWSM unbiased estimator of 𝑌𝐴𝐵 with 
the data of the sample 𝑆𝐵, as  
(29) ?̂?𝐴𝐵
𝐵 = ∑
1
𝜋𝐶𝑘  
∑
1
𝜋2𝐶|𝑘
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗𝑦𝑗
𝑗∈𝑆𝐶
𝕀(𝐿𝑣𝑗 ≥ 1)
𝑘∈𝑆𝐶
. 
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The information on the intersection of the samples with the subpopulation 𝑈𝐴𝐵 may be 
collected either during the interview or with digital contact tracing.  
Singh and Mecatti (2011) give an in-depth illustration of the different approaches in 
literature to find the optimal value of 𝛼 in the context of multiple frames surveys. Hartley 
(1962, 1974) proposed choosing 𝛼 in (14) to minimize the variance of ?̂?. Because the 
frames are sampled independently, the variance of ?̂? is: 
 
(31)     𝑉(?̂?) = 𝑉(?̂?𝐴) + 𝑉(?̂?𝐵) + 𝛼
2 𝑉(?̂?𝐴𝐵
𝐴 ) + (1 − 𝛼)2𝑉(?̂?𝐴𝐵
𝐵 ) + 
−2𝛼𝐶𝑜𝑣 (?̂?𝐴𝐵
𝐴 , ?̂?𝐴) − 2(1 − 𝛼) 𝐶𝑜𝑣 (?̂?𝐴𝐵
𝐵 , ?̂?𝐵). 
 
Thus, for general survey designs, the variance-minimizing value of 𝛼 is: 
 
(32)       𝛼𝑜𝑝𝑡 =
𝑉(?̂?𝐵) + 𝐶𝑜𝑣 (?̂?𝐴𝐵
𝐵 , ?̂?𝐵) − 𝐶𝑜𝑣 (?̂?𝐴𝐵
𝐴 , ?̂?𝐴)
𝑉(?̂?𝐴) + 𝑉(?̂?𝐵)
. 
 
Unfortunately, the above quantity depends on the variable y. 
Note that if one of the covariances in (32) is large, it is possible for 𝛼𝑜𝑝𝑡 to be smaller than 
0 or greater than 1. Hartley (1974) suggests opting for this alternative expression: 
 
(33)       𝛼∗ =
𝑉(?̂?𝐵)
𝑉(?̂?𝐴) + 𝑉(?̂?𝐵)
. 
Unbiasedness and variance. The proof of unbiasedness and the calculation of the variance 
of the estimator ?̂?𝐴𝐵 are straightforward extensions of what has been illustrated in 
sections 6.1 and 6.2. 
Remark 7. Lavallé and Rivest (2012) propose to estimate the total Y with the Generalised 
Capture-Recapture Estimator (GCRE), which makes a joint use of capture-recapture 
Petersen estimator with GWSM estimators. In our context, the GCRE estimator may be 
expressed as: 
 
(34)        ?̂?𝐺𝐶𝑅𝐸 =
?̂?𝐴 ?̂?𝐵
?̂?𝐴𝐵(𝑆𝐴∩𝑆𝐵)
, 
 
where ?̂?𝐴𝐵(𝑆𝐴∩𝑆𝐵)is the estimate of 𝑌𝐴𝐵 computed on the basis of the units observed in the 
intersection sample 𝑆𝐴 ∩ 𝑆𝐵 in which the sampling weights for producing the estimates 
from 𝑆𝐴 ∩ 𝑆𝐵 are given in formula (11) in the above mentioned paper. With respect the 
expression (28), the GCRE estimator allows estimating the hidden population which 
would not be visible with either the public health structure nor with the panel survey (e.g. 
the people died at home) being very difficult to capture with the usual survey techniques. 
The main problem for adopting the GCRE estimator is that it would require an overlap of 
the samples of groups A and B. 
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Remark 8. In Section 8, and in Appendix we see that the maximum of efficiency is gathered 
from sampling from 𝑈𝑣. At the same time, collecting the value of the variable 𝐿𝐶𝑗 could be 
complex for the need to set-up a following a back-tracing process. Thus, a feasible 
alternative strategy for the estimation of Y could be represented by  
 
 ?̂?𝑎𝑙𝑡 = ?̂?𝐴 + ?̂?𝐶 − ?̂?𝐴𝐶
𝐴 , 
 
where  ?̂?𝑐 is the standard Narain-HT estimate of the total of 𝓎 in 𝑈𝐶 and ?̂?𝐴𝐶
𝐴  is the GWSM 
estimate of the total of 𝓎 in the intersection of 𝑈𝐴 with 𝑈𝐶 obtained by the sample 𝑆𝐴, being 
?̂?𝑐 = ∑
1
𝜋𝐶𝑘  
𝑦𝑘
𝑘∈𝑆𝐶
, 
?̂?𝐴𝐶
𝐴 = ∑
1
𝜋𝑣𝑘  
∑
1
𝜋2𝑣|𝑘
1
𝐿𝑣𝑗
𝑙𝑘,𝑗
𝑗 ∈𝑆𝑣𝑘𝑘∈𝑆𝑣
𝑦𝑗𝕀[(𝐿𝑗 − 𝐿𝐶𝑗) ≥ 1], 
in which 𝐿𝑗 is the total of contacts of the unit j. 
 
7. Sample design for the follow-up of the survey in subsequent waves 
The observational scheme proposed in the above sections is set up as a cross sectional 
survey. However, it can be adapted to monitoring the evolution of the number of infected 
people over time, according to a mechanism which is updated as in a chain mechanism 
time after time. While an in-depth study of this aspect deserves a separate study, we limit 
ourselves to introduce here the topic and to provide some initial indication.  
Let consider two consecutive points in time, say 𝑡 = 0 and 𝑡 = 1.  
The person k  verified as infected at time 0, hence denoted as 𝑣0,𝑘 = 1 , may still be 
infected (𝑣1,𝑘 = 𝑦1,𝑘 = 1)  or she/he may no longer be infected (𝑦1,𝑘 = 0) by death 
(denoted by the dichotomous variable 𝑑1,𝑘 = 1) or healing (denoted by the dichotomous 
variable ℎ1,𝑘 = 1).  
The total of the 𝓎 variable at time 1, may then be defined as: 
 
(35)    𝑌1 = 𝑌0 + ∆𝐷0→1 + ∆𝐻0→1 + ∆𝑌1, 
 
where 𝑌0 is the total number of infected at time 0 and: 
(36)    ∆𝐷0→1 = ∑ 𝑦0,𝑘
𝑘∈𝑈
𝑑1,𝑘 , ∆𝐻0→1 = ∑ 𝑦0,𝑘
𝑘∈𝑈
ℎ1,𝑘  , ∆𝑌1 = ∑ (1 − 𝑦0,𝑘)
𝑘∈𝑈
𝑦1,𝑘 . 
In equation (36) the quantity (𝑌0 + ∆𝐷0→1 + ∆𝐻0→1) indicates the total number of verified 
infected people at time 0 who are still infected at time 1, while the quantity , ∆𝑌1 denotes 
the total number of new infected.  
The updating of the sampling structures illustrated in the previous sections allows to 
obtain a direct estimate of each of the components of (35), as illustrated in the Figure 2.  
The total ∆𝑌1can be estimated, as described in Section 5, using two sources of data, 
namely: 
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• the sample 𝑆1,𝑣 , which automatically captures the new entrances in the population 
of the verified infected at time 1, ∆𝑈1,𝑣, since the sampling selection is carried out 
continuously over time on this population. Then a sample of their contacts could be 
carried out as described in section 4.2, obtaining the sample 𝑆1,𝐴; 
• the panel 𝑆0,𝐶  selected at the time 𝑡 = 0, which is updated over time, since the tests 
carried out at time 𝑡 = 1 on the individuals of 𝑆0,𝐶  individuate the new infected 
people of the panel. Then tracking the contacts of the infected people allows to 
obtain the sample 𝑆1,𝐵 . 
The estimation of the totals  (𝑌0 + ∆𝐷0→1 + ∆𝐻0→1) can be obtained by following up the 
health status of the infected people captured in the samples 𝑆0,𝐴 and 𝑆0,𝐵 of time 0. The 
estimates are then obtained with the sampling weights computed at time 0. 
Therefore, we have: 
 
(37)    ?̂?1 = ?̂?0 + ∆?̂?0→1 + ∆?̂?0→1 + ∆?̂?1, 
 
where ?̂?0 , ∆?̂?0→1, ∆?̂?0→1, ∆?̂?1 are the direct estimates of the corresponding quantities 
𝑌0 , ∆𝐷0→1, ∆𝐻0→1, ∆𝑌1. The above mechanism can be updated in a chain mode, thus 
obtaining the estimate for the time 𝑡 > 1 as: 
 
(38)   ?̂?𝑡 = ?̂?𝑡−1 + ∆?̂?𝑡−1→𝑡 + ∆?̂?𝑡−1→𝑡 + ∆?̂?𝑡 .  
 
Figure. 2.  Follow up of samples over time 
 
 
21 
 
8. A note on the efficiency of the strategy  
In order to derive the efficiency of the estimators we need to specify different cases that 
may occur, related to the intersection between the samples from the population groups A 
and B. Here we consider only two rather realistic cases, which are illustrated in Figure 3. 
• Case 1. Samples from groups A and B have the same size, with a strong intersection 
between the two groups. This case could characterize the situation in which there is 
no control of the infection. In this case, the proportions 𝛾𝐴 = 𝑌𝐴𝐵 𝑌𝐴⁄  and 𝛾𝐵 = 𝑌𝐴𝐵 𝑌𝐵⁄  
are slightly smaller than 1. Thus, it is possible to consider 𝛾𝐴 ≅ 1 and 𝛾𝐵 ≅ 1.  
• Case 2. Sample from Group A is much smaller than the sample from group B with a 
strong intersection between the sample from group A and the intersection between 
the two samples. In this case, we can consider 𝛾𝐴 ≅ 1 and 𝛾𝐵 ≪ 1. This case could be 
that in which the infection is controlled by locking down the people. 
 
Figure. 3.  Two realistic cases of intersection between the samples from groups A and B   
 
 
Below, we summarise a result for simple random sampling, which may be useful to 
understand the efficiency of the strategy better here proposed. We give all the details in 
the Appendix.  
Let us suppose selecting the sample S  of size n from U  with a SRSWOR design. Let  
(39)  ?̂?𝐻𝑇,𝑆𝑅𝑆 = ∑
𝑁
𝑛
𝑦𝑘 =
𝑛
𝑘=1
∑
1
𝑓
𝑦𝑘
𝑛
𝑘=1
 
be the HT estimate of 𝑌, where 𝑓 = 𝑛/𝑁. Let 𝜇 = 𝑌/𝑁 be the proportion of infected people 
in the overall population.   
For N  large and 𝑓 small, the Anticipated Variance (AV) of ?̂?𝐻𝑇,𝑆𝑅𝑆 can be approximated by 
(Falorsi and Righi, 1915, Appendix 4): 
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(40)  𝐴𝑉(?̂?𝐻𝑇,𝑆𝑅𝑆) =
𝑁
𝑓
𝜇(1 − 𝜇). 
Let  𝑈𝑦𝑙 = {𝑘, 𝑗: 𝑦𝑘 = 1, 𝑦𝑘𝑙𝑘,𝑗 = 1; 𝑘, 𝑗 = 1, … , 𝑁 } denote the sub-population of infected 
people and of those who have had contacts with them. Let 𝜗 = 𝑌/#𝑈𝑦𝑙 be the proportion  
of infected people in 𝑈𝑦𝑙 , being 𝜇 ≪ 𝜗. Let us supposed to allocate the sample S 
proportionally between the two frames 𝑈𝑣 and 𝑈𝐶  and to select a SRSWOR in each frame. 
Thus, the sample sizes for 𝑈𝑣 and 𝑈𝐶  are 𝑃𝑣𝑛 and (1 − 𝑃𝑣)𝑛, respectively.   
The GWSM estimates of the totals 𝑌𝐴 , 𝑌𝐵 , 𝑌𝐴𝐵 and Y are:   
(41)   ?̂?𝐴,𝑆𝑅𝑆 = ∑
1
𝑓
𝑃𝑣𝑛
𝑘=1
∑
1
𝐿𝑣𝑗
 𝑙𝑘,𝑗
𝑁
𝑗=1
𝑦𝑗    , ?̂?𝐵,𝑆𝑅𝑆 = ∑
1
𝑓
𝑦𝑘
(1−𝑃𝑣)𝑛
𝑘=1
∑
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗
𝑁
𝑗=1
𝑦𝑗 , 
?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 = ∑
1
𝑓
𝑃𝑣𝑛
𝑘=1
∑
1
𝐿𝑣𝑗
 𝑙𝑘,𝑗
𝑁
𝑗=1
𝑦𝑗 (𝐿𝐶𝑗 ≥ 1) , 
?̂?𝐴𝐵,𝑆𝑅𝑆
𝐵 = ∑
1
𝑓
(1−𝑃𝑣)𝑛
𝑘=1
𝑦𝑘 ∑
1
𝐿𝐶𝑗
 𝑙𝑘,𝑗
𝑁
𝑗=1
𝑦𝑗 (𝐿𝑣𝑗 ≥ 1). 
?̂?𝑆𝑅𝑆 = ?̂?𝐴,𝑆𝑅𝑆 − 𝛼?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 + ?̂?𝐵,𝑆𝑅𝑆 − (1 − 𝛼)?̂?𝐴𝐵,𝑆𝑅𝑆
𝐵 . 
Assuming that the number of contacts, L, is roughly constant in  𝑈, the AV of ?̂?𝑆𝑅𝑆 is 
(42)   𝐴𝑉(?̂?𝑆𝑅𝑆) = 𝐴𝑉(?̂?𝐴,𝑆𝑅𝑆 − 𝛼?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) + 𝐴𝑉[?̂?𝐵,𝑆𝑅𝑆 − (1 − 𝛼)?̂?𝐴𝐵,𝑆𝑅𝑆
𝐵 ] 
where  
(43)  𝐴𝑉(?̂?𝐴,𝑆𝑅𝑆 − 𝛼?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) ≅
𝑃𝑣𝑁
𝑓
1
𝐿
𝜗[(1 − 𝜗)(1 − 2𝛼𝛾𝐴) + 𝛼
2𝛾𝐴(1 − 𝛾𝐴𝜗)] 
and  
(44)  𝐴𝑉(?̂?𝐵,𝑆𝑅𝑆 − (1 − 𝛼)?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) 
≅ (1 − 𝑃𝑣)𝑁
1
𝑓𝐿𝜇
𝜗[(1 − 𝜇𝜗) + (1 − 𝛼)2𝛾𝐵(1 − 𝛾𝐵𝜇𝜗) − 2(1 − 𝛼)𝛾𝐵(1 − 𝜇𝜗)]. 
Comparing the expressions (42) and (40), we have that the efficiency of the proposed 
strategy can be defined as the ratio of the two AVs: 
(45)    𝐸𝑓𝑓(?̂?𝑆𝑅𝑆) =
𝐴𝑉(?̂?𝑆𝑅𝑆)
𝐴𝑉(?̂?𝐻𝑇,𝑆𝑅𝑆)
 
=
1
𝐿 𝜗
[(1 − 𝜗)(1 − 2𝛼𝛾𝐴) + 𝛼
2𝛾𝐴(1 − 𝛾𝐴𝜗)]
𝜇(1 − 𝜇)
𝑃𝑣 + 
(46)       +
1
𝐿𝜇 𝜗
[(1 − 𝜇𝜗) + (1 − 𝛼)2𝛾𝐵(1 − 𝛾𝐵𝜇𝜗) − 2(1 − 𝛼)𝛾𝐵(1 − 𝜇𝜗)]
𝜇(1 − 𝜇)
(1 − 𝑃𝑣). 
Looking at expression (46), we can highlight the following results: 
 The effectiveness of the strategy is maximum for case 1. 
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 The efficacy is maximum for the sampling from 𝑈𝑣  in which is realistic to have 
1
𝐿
𝜗[(1 − 𝜗)(1 − 2𝛼𝛾𝐴) + 𝛼
2𝛾𝐴(1 − 𝛾𝐴𝜗)] < 𝜇(1 − 𝜇). 
 The efficacy could be lower or null for the sampling from 𝑈𝐶  in which the condition   
1
𝐿𝜇
𝜗[(1 − 𝜇𝜗) + (1 − 𝛼)2𝛾𝐵(1 − 𝛾𝐵𝜇𝜗) − 2(1 − 𝛼)𝛾𝐵(1 − 𝜇𝜗)] < 𝜇(1 − 𝜇), 
 is not always given. 
Thus, a good strategy could be that of oversampling in 𝑈𝑣 and having a small sample for 
𝑈𝐶 .   
 
9. Empirical evaluations of the proposed method: a Monte Carlo study  
 
9.1 Artificial data generation 
Since it is not possible, at this stage, to include a numerical illustration using real-life 
sample data, in this section we report the results of a series of Monte Carlo experiments 
which justify numerically our proposed ideas and show their statistical performances in 
an artificial, although as realistic as possible, context. 
Before showing our simulation results, we need to clarify the criteria we used in the data 
generation process and those employed in the generation of the geographical map on 
which data are observed. This second element is essential, given the peculiar nature of the 
transmission mechanism which requires physical proximity between infected people.  
First of all, in order to simulate an artificial population describing the time evolution of an 
epidemics, we considered a popular model constituted by a system of six differential 
equations which, in each moment of time, describe six categories of individuals, namely: 
the susceptibles (S), those exposed to the virus (E), the infected with symptoms (I), those 
without symptoms (A) and those that are removed from population either because healed 
(R) or dead (D). This modelling framework is due to the seminal contribution of Hamer 
(1906), Kermack and McKendrick (1927) and Soper (1929) and it is often referred to as 
the “SIR model” from the initials of the categories considered in the first simplified 
formulation: Susceptibles, Infected and Removed. A comprehensive overview of this 
model is contained in Cliff et al. (1981). See also Vynnycky and White (2010). Figure 4 
describes diagrammatically the transition between the 6 categories. For the data random 
generation, we assumed that, if infected, a susceptible element of the population (S) will 
remain in the exposed state (E) for 5 days. After that period the subject can become either 
infected with symptoms (I) with probability 0.25 or without (asymptomatic; symbol A) 
with probability 0.75. The asymptomatic will remain infected (and so still able to transmit 
the virus) for 14 days. After this period all the asymptomatic will be considered healed 
and will pass to the category removed (R). In contrast, the infected people showing 
symptoms will be healed with probability 0.85 or die (D) with probability 0.15 (case 
death rate).  
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Figure 4. The six basic categories of our simulation model and their transition pattern 
 
 
For the map generation we considered a population distributed into 25 spatial units laid 
on a 5-by-5 regular squared lattice grid. Each square of the grid contains a number of 
individuals randomly drawn from a uniform distribution ranging between 800 and 1,000. 
After a simulation exercise with these parameter values, we obtained an artificial 
population with a total of 22,217 individuals.  
This geographical representation is very general in that the map thus generated can 
represent, e. g., a city divided into blocks or a region divided into smaller spatial union or 
any other meaningful geographical partition. 
The contagion mechanism is favoured by people mobility. In our exercise, we assumed 
that in any moment of time a certain percentage m of the population can move between 
the squares. We distinguish two epidemic phases. In Phase 1 people is free to move and 
such percentage is m=0.03, while Phase 2 describes a period of lockdown when mobility 
is discouraged and m=0.01. In particular, we considered Phase 1 involving a period of 4 
weeks and Phase 2 related to the period of the 8 subsequent weeks. The commuting 
during the lockdown period is not only limited by the number of people who move, but 
also by the extent of their movements. This is a further simulation parameter which is 
generated by a uniform distribution ranging from -4 to 4 during Phase 1 (thus allowing 
movements in and out the cells) and between -1 and 1 during the Phase 2.  
Given the mobility pattern described above, contagion is determined by the social 
interaction and the contact opportunities. The number of contacts in each square of the 
grid is assumed to be determined by a random number drawn from a Poisson distribution 
with parameter, say cn, while the number of people involved in the movements is also a 
Poisson number characterised but a different parameter cp. Given these assumptions, a 
contagion occurs in the following way. If in a meeting it is present at least one 
asymptomatic or an exposed person, im susceptibles will be infected moving in the status 
of the Exposed. In our runs of the simulation, we considered Phase 1 characterised by the 
following parameters cn = 20;  cp = 5;  im = 3. In contrast, during Phase 2 the three 
parameters become cn = 3;  cp = 3; im = 2 reflecting the decreased chances of contacts 
between people. Figure 2 describes the time evolution of the six categories of people in 
our simulated epidemics. As already said, we consider Phase 1 constituted by 4 weeks 
(day 1 to day 28) and Phase 2 lasting 8 weeks (day 29 to day 84). Figure 5 shows that. 
despite the many assumptions that we were forced to include in the simulation, the 
contagion curves are very similar to those observed worldwide in the recent 2020 SARS-
CoV-2 pandemics. 
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Figure 5. Time evolution of the six categories of people in the simulated epidemics. Phase 
1 refers to days 1- 28. Phase 2 refers to days 29-84.  
 
 
 
9.2 Simulation results 
We present the main results obtained in the simulation exercise. Using the artificial 
population generated as described in the previous section, we considered the situation of 
a repeated sampling survey realized in three moments of time, namely at day 15 (during 
the beginning of Phase 1), at day 25 (still in Phase 1, but in a situation closer to a plateau) 
and at day 35, during the period of lockdown. The situation of the infected in the three 
moments of time is reported in Table 1 distinguishing between the samples in groups A, 
B and their intersection (see Figure 3). 
Table 1. True simulated population values of the infected (distinguished for the two 
subpopulations called , Groups A, B and their intersection) at different days 
Group 
considered 
Day 15 Day 25 Day 35 
𝑌𝐴 42 374 1,041 
𝑌𝐵 126 875 1,432 
𝑌𝐴𝐵 39 372 1,018 
Total of infected  129 877 1,455 
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For group A we fixed the parameter g =  0.9 while for group B the parameter f and 𝜈 are 
fixed as follows: 𝑓 = 0. ; 𝜈 = 12. 
The sample size obtained with such parameters’ definition (both excluding and including 
the contacts) are reported in Table 2 by distinguishing 4 sample situations, namely: (i) 
A1B2 when both the individuals belonging to group A and their contacts are totally 
sampled while in group B both the non-infected and all contacts are sampled; (ii) A1B3 
when both the individuals belonging to group A and their contacts are sampled while in 
group B the non-infected are sampled with all contacts with a maximum of 𝜈 = 12; (iii) 
A2B2 when all individuals belonging to group A, but only a subset of their contacts are 
included in the sample and in group B the non-infected are sampled with all their contacts; 
and, finally, (iv) A2B3 when all individuals belonging to group A, but only a subset of their 
contacts are included in the sample while in group B the non-infected are sampled with 
all their contacts, but only up to a maximum of 𝜈 = 12 individuals. Notice that in day 35 
we have fewer contacts in the sample than in day 25 due to the lockdown measures 
considered. 
Table 2. Total number of sample units including and excluding the contacts at different 
days and in the various sampling schemes 
Day Proportion 
of infected 
in the 
population 
Sampling 
scheme 
Sampling 
units 
without 
contacts 
Sampling 
units 
with 
contacts 
15 0.006 
A1B2 4,130 4,741 
A1B3 4,130 4,736 
A2B2 4,130 4,741 
A2B3 4,130 4,736 
25 0.042 
A1B2 4,198 7,650 
A1B3 4,198 7,634 
A2B2 4,198 7,650 
A2B3 4,198 7,634 
35 0.070 
A1B2 4,361 7,545 
A1B3 4,361 7,514 
A2B2 4,361 7,545 
A2B3 4,361 7,514 
 
The main results of the simulation are reported in Table 3 which shows that in all 
sampling settings the relative bias is very small and our estimators outperform 
dramatically the simple random sampling in terms of efficiency (the ratio of the standard 
error of the proposed estimator, computed by the simulation, over that of the HT 
estimator of a simple random sampling without replacement). In particular, the relative 
bias is of the order of 0.01 % during Phase 1, while during Phase 2 it depends on the 
sampling scheme adopted with a greater precision when both the individuals belonging 
to group A and their contacts are included in the sampling. In contrast, the relative bias 
obviously increases when only a subset of the contacts is observed. Furthermore, our 
method outperforms the simple random sample also in terms of efficiency. Similar to the 
case of the bias, the relative advantage with respect to simple random sample is greater 
in the case of the A1 sample scheme when all selected individuals and their contacts are 
included in the sample while it is lower in the case of A2 when only a subset of them is 
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observed. Moreover, Table 3 also displays a decrease in the relative advantage of our 
method in the day 35 wave where, due to the lockdown restrictions, the number of 
contacts is much more limited. 
The results presented here depend essentially on the particular setting of the (many) 
parameters involved in the simulation which describe different epidemic evolutions. To 
mitigate such a subjectivity, we also run many other Monte Carlo experiments using 
different parameter values. Although available upon request to the authors, these results 
are not reported here for the sake of succinctness. However, they all confirm the same 
features of a very low relative absolute bias involved with our proposed method and of its 
superiority with respect to the simple random scheme in terms of efficiency.  
 
Table 3: Main results of the simulation study for the various sampling schemes at different 
days 
Days 
 
 
 
 
 
 
 
 
(1) 
Percentage 
of infected 
people in 
the 
population 
 
 
 
 
(2) 
Sampling 
scheme 
 
 
 
 
 
 
 
(3) 
Estimated 
total 
infected  
(average on 
500 
simulations) 
 
 
 
(4) 
𝛼* 
 
 
 
 
 
 
 
 
(5) 
Standard 
error 
 
 
 
 
 
 
 
(6) 
Coefficient 
of 
variation  
 
(6)
(4)
𝑥100 
 
 
 
(7) 
True 
population 
value 
(from 
Table 1) 
 
 
 
 
(8) 
Relative 
absolute 
bias 
 
|(8) − (4)|
(4)
 
 
 
 
(9) 
Relative 
efficiency 
with 
respect to 
the simple 
random 
sample 
without 
contacts 
(10) 
Relative 
efficiency 
with 
respect to 
the simple 
random 
sample 
with 
contacts 
(11) a 
15 0.0058 
A1B2 128.99 0 0.01 0.09 129 0.0001 0.0006 0.0006 
A1B3 128.99 0 0.01 0.09 129 0.0001 0.0006 0.0006 
A2B2 128.75 0 1.56 0.97 129 0.0019 0.0659 0.0718 
A2B3 128.75 0 1.56 0.97 129 0.0019 0.0659 0.0718 
25 0.0394 
A1B2 876.83 0 0.17 0.05 877 0.0001 0.0027 0.0041 
A1B3 876.84 0 0.16 0.05 877 0.0001 0.0027 0.0040 
A2B2 876.90 1 0.48 0.08 877 0.0001 0.0080 0.0120 
A2B3 877.02 0.48 2.43 0.18 877 0.0000 0.0403 0.0605 
35 0.0654 
A1B2 1,455 0 0 0 1.455 0 0 0 
A1B3 1,455 0 0 0 1.455 0 0 0 
A2B2 1.461.59 0 9.78 0.21 1.455 0.0045 0.1310 0.1895 
A2B3 1.461.59 0 9.78 0.21 1.455 0.0045 0.1310 0.1895 
(a)The relative efficiency is computed as the ratio of the standard error of the proposed estimator 
(computed by the simulation) over that of the HT estimator of a simple random sampling without 
replacement. 
 
10. Conclusions and future challenges 
The aim of this paper is to draw the attention of researchers and decision makers on the 
need of observing the characteristics of the Covid19 pandemics through a formal sample 
design thus overcoming the limitations of data collected on a convenience basis. Only in 
this way will we be able to produce both reliable estimates of the current situation and 
forecasts of the future evolution of the epidemics so as to take empirically grounded 
decisions about public health monitoring and surveillance, especially in the phase of the 
exit from the epidemic peak and of relaxation of the quarantine measures. 
In such a situation, it is essential to set up a system of data collection which allows 
statistically significant comparisons through time and across different geographic areas, 
by taking into account the different economic, demographic, social, environmental and 
cultural contexts. 
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We believe that a clear knowledge of the phenomenon is necessary also for the awareness 
and behaviour to be adopted by the population. Trust and sharing must be grounded on a 
solid information base. 
In comparison with other possible observational strategies the proposal has three 
elements of strength, namely: 
• Relevance. The proposed sample scheme, designed to capture most of the infected 
people through an indirect sampling mechanism, not only aims at providing a 
snapshot of the phenomenon in a single moment of time, but it is designed so as to 
become a continuous survey, repeated in several waves through time, also taking 
into account different target variables in the different stages of development of the 
epidemic. It contributes to implement a statistical surveillance system on the 
epidemic to be integrated with the existing systems managed by the health 
authorities;  
• Statistical quality. In the paper the properties of the estimators have been formally 
proved and confirmed analysing the results of a set of Monte Carlo experiments;  
they guarantee their reliability in terms of unbiasedness and higher efficiency with 
respect to the simple random sample; 
• Timeliness. The sample design is rapidly operational as it is required by the 
emergency we are experiencing; indeed, the paper represents the statistical 
formalization of a recent proposal (Alleva et al., 2020) that has been accompanied 
by a technical note which describes the different phases in which it is divided, the 
subjects involved and the crucial points for its success (Ascani, 2020). 
Although our effort to progress on the subject in this phase of emergency, there is floor 
for a lot of methodological statistical research for setting up statistical instruments for 
producing reliable and timely estimates of the phenomenon. Indeed, from a 
methodological point of view, while in the paper we have fully derived the properties of 
the estimators in the cross-sectional case, the properties in subsequent waves still need 
to be proved formally. Among other aspects to be developed, we mention those related to 
time and spatial correlations, useful both for modelling the phenomenon and for 
designing efficient spatial sampling so as to achieve the same level of precision with fewer 
sample units (Arbia and Lafratta, 2002). A specific extension of the spatial sampling 
techniques to be further developed is the use of capture/recapture techniques (Borchers, 
2009; Lavallée and Rivest, 2012) which would require an overlap of the samples of groups 
A and B. A further improvement to be explored could derive from applying the Dorfmann 
procedure (Dorfmann, 1943) to reduce number of the tests and cost. 
In addition to the methodological advances, other general aspects to be developed with 
different specialists are the integration of the statistical system we propose with the 
health authority's surveillance system for the infected and the use for statistical purposes 
of the contact-tracking devices, both in the identification of contacts and in the measure 
of the propensity to travel and of the connected risks. To this aim, it could be interesting 
to study the possibility of considering, within our framework, the proposal developed by 
Saunders-Hastings et al. (2017) who address the problem via a model approach. The need 
to monitor over time the pandemics should represent the drive for building an integrated 
surveillance system. This should merge within a unified database three different pieces of 
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information: (i) the information collected by the administrative institutions when 
receiving and treating individuals that have turned to the healthcare system; together, (ii) 
the statistical information collected on purpose with the aim to accurately measure the 
diffusion of the infection and, finally, (iii) the data obtained through new sources for 
tracking the movements of people and of their contacts. 
A third line of extension of our proposal concerns the operational point of view. Indeed the 
sample design described in detail in Section 5 should be accompanied by the rapid 
definition of some key points: 
• a control room that ensures the necessary inter-institutional collaboration to guide 
field operations (Health Authorities, at national and regional level, Statistical 
Offices, others); 
• an effective information campaign among the population to promote their 
participation; the legal framework to assure the collection and the analysis of 
personal data; 
• the medical testing procedure to consider for the selected population (swabs, 
blood testing and DNA mapping); 
• the geographical-temporal estimate domains of interest and the sample dimension 
on the basis of the informative needs and the available financial and organizational 
resources;  
• the frequency of sampling for groups A and B, as well as the length of stay in the 
panel of group B; 
• the socio-demographic characteristics, living condition and mobility behaviors to 
be collected at individual and familiar level to shed light on relative risks and to 
evaluate the effects of the policies adopted to modify the evolution of the epidemic. 
This can only be achieved if epidemiologists, virologists, administrators of healthcare 
institutions work in conjunction with experts in mathematical and statistical modeling 
and forecasting and in the evaluation of public policies. 
We designed the sampling mechanism having in mind the Italian situation; and we proved 
its feasibility defining the previous key point to estimate times and costs (Alleva et al., 
2020)12. In adopting the suggested strategy, different countries may require adjustments 
taking into account the peculiarities of the specific health system and institutional 
framework. In this direction it will be essential the contribution of the National Statistical 
Offices, as well as common actions and sharing experiences at the European and 
worldwide level.  
The emergency connected with the diffusion of Covid-19 is an incredible occasion for 
building up a solid informative infrastructure for researchers and decision makers. We 
must also feel the duty and responsibility to prepare to face possible future outbreaks of 
pandemics in an informed way.  
 
12 The sample size to assure a certain level of accuracy of the estimates depends on the Base Rate of 
infection. The unit cost of the swab and serological administering relies on the level of involvement in the 
survey of the public health authorities. The total cost depends on the length and the periodicity of the 
panel survey. For Italy we estimated the cost of data collection at national and regional level (21 regions), 
in case of 3 months of monitoring, panel survey every 15 days and a Base Rate of infection 0,04. 
Concerning Groups A and B, the sample sizes are 1,000 and 1,200 units, that implies 6,000 and 7,200 
swabs and a total cost of 210,000 and 252,000 euros. 
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APPENDIX 
For the estimator (39), the following model can be assumed, 
(𝐴1)    𝐸𝑀(𝑦𝑘) = 𝜇, 𝑉𝑀(𝑦𝑘) = 𝜇(1 − 𝜇)  for 𝑘 = 1, … , 𝑁, 
where 𝐸𝑀 and 𝑉𝑀 denote the model expectation and variance. According to the above 
the Anticipated Variance of the estimate ?̂?𝐻𝑇,𝑆𝑅𝑆  may be defined as (Falorsi and Righi, 
1915, Appendix 4): 
(𝐴2)  𝐴𝑉(?̂?𝐻𝑇,𝑆𝑅𝑆) =
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(𝐴3)                     ≅ ∑
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𝑛
𝜇(1 − 𝜇)
𝑁
𝑘=1
  = ∑
1
𝑓
𝜇(1 − 𝜇) =
𝑁
𝑘=1
𝑁
𝑓
𝜇(1 − 𝜇). 
The approximation (A3) holds for N  large and 𝑓 small. 
For the estimators (41), we can introduce the following model  
(𝐴4)    𝐸𝑀(𝑦𝑘) = 𝜗, 𝑉𝑀(𝑦𝑘) = 𝜗(1 − 𝜗)  for 𝑘 ∈ 𝑈𝑦𝑙 . 
Furthermore, for the variables 𝑦𝑗 (𝐿𝐶𝑗 ≥ 1) and 𝑦𝑗 (𝐿𝑣𝑗 ≥ 1) we can adopt the 
hypothesis that  the probabilities   
(𝐴5)    𝑃(𝐿𝐶𝑗 ≥ 1|𝑘 ∈ 𝑈𝑣 ∩ 𝑙𝑘,𝑗 = 1 ) ≅ 𝛾𝐴 
𝑃(𝐿𝑣𝑗 ≥ 1|𝑘 ∈ 𝑈𝐶 ∩ 𝑦𝑘,𝑗 𝑙𝑘,𝑗 = 1 ) ≅ 𝛾𝐵  
are roughly constant. Then we may derive the following models  
 (𝐴6)      𝐸𝑀[𝑦𝑗 (𝐿𝐶𝑗 ≥ 1)] = 𝜗𝛾𝐴, 𝑉𝑀[𝑦𝑗 (𝐿𝐶𝑗 ≥ 1)] = 𝜗𝛾𝐴(1 − 𝜗𝛾𝐴)  for𝑘 ∈ 𝑈𝑣 ∩ 𝑙𝑘,𝑗 = 1, 
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                  𝐸𝑀[𝑦𝑗  (𝐿𝑣𝑗 ≥ 1)] = 𝜗𝛾𝐵, 𝑉𝑀[𝑦𝑗 (𝐿𝑣𝑗 ≥ 1)] = 𝜗𝛾𝐵(1 − 𝜗𝛾𝐵)  for 𝑘 ∈ 𝑈𝐶 ∩ 𝑦𝑘,𝑗  𝑙𝑘,𝑗
= 1. 
Let us assume that number of contacts, L, are roughy constant in  𝑈. Then, the total 
number of contacts deriving from the two the frames (𝑈𝑣 and 𝑈𝐶) are  
𝑇𝐿𝑣 = ∑ ∑  𝑙𝑘,𝑗
𝑁
𝑗=1
𝑃𝑣𝑁
𝑘=1
= 𝑃𝑣𝑁𝐿  , 𝑇𝐿𝐶 = ∑ 𝑦𝑘 ∑  𝑙𝑘,𝑗
𝑁
𝑗=1
(1−𝑃𝑣)𝑁
𝑘=1
≅ 𝜇(1 − 𝑃𝑣)𝑁𝐿. 
By considering the reasonable assumptions of an uniform distribution of the contacts 
among the units, we have: 
𝐿𝑣𝑗 ≅
𝑃𝑣𝑁𝐿  
𝑃𝑣𝑁
= 𝐿   and  𝐿𝐶𝑗 ≅
𝜇(1 − 𝑃𝑣)𝑁𝐿  
(1 − 𝑃𝑣)𝑁𝐿
= 𝐿𝜇.   
Adopting the model (𝐴1) in the case we do not know if the unit  𝑘 ∈ 𝑈𝑦𝑙 and the models 
(A4) for 𝑘, 𝑗 ∈ 𝑈𝑦𝑙, then the estimates ?̂?𝐴,𝑆𝑅𝑆 and ?̂?𝐵,𝑆𝑅𝑆  can be approximated by 
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Then, for the estimates derived from 𝑆𝐴, we have: 
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1
𝑓
𝑃𝑣𝑁
𝑘=1
∑
1
(𝐿𝜗)2
 𝑉𝑀
𝐿
𝑗=1:𝑗∈𝑈𝑘
(𝑦𝑗) = ∑
1
𝑓
𝑃𝑣𝑁
𝑘=1
∑
1
𝐿2
 
𝐿
𝑗=1:𝑗∈𝑈𝑘
𝜗(1 − 𝜗) 
= ∑
1
𝑓
𝑃𝑣𝑁
𝑘=1
𝐿
(𝐿𝜗)2
𝜗(1 − 𝜗) =
𝑃𝑣𝑁
𝑓
1
𝐿
𝜗(1 − 𝜗), 
𝐴𝑉(?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) = ∑
1
𝑓
𝑃𝑣𝑁
𝑘=1
∑
1
𝐿2
 
𝐿
𝑗=1:𝑗∈𝑈𝑘
𝛾𝐴𝜗(1 − 𝛾𝐴𝜗) =
𝑃𝑣𝑁
𝑓
1
𝐿
𝛾𝐴𝜗(1 − 𝛾𝐴𝜗) 
𝐴𝐶𝑜𝑣(?̂?𝐴,𝑆𝑅𝑆 , ?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) = ∑
1
𝑓
𝑃𝑣𝑁
𝑘=1
𝐿
𝐿2
𝐶𝑜𝑣𝑀[𝑦𝑗 (𝐿𝐶𝑗 ≥ 1), 𝑦𝑗] =
𝑃𝑣𝑁
𝑓
1
𝐿
𝛾𝐴𝜗(1 − 𝜗). 
Putting together the above results we have: 
(𝐴9)   𝐴𝑉(?̂?𝐴,𝑆𝑅𝑆 − 𝛼?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) = 𝐴𝑉(?̂?𝐴,𝑆𝑅𝑆) + 𝛼
2𝐴𝑉(?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) − 2𝛼𝐴𝐶𝑜𝑣(?̂?𝐴,𝑆𝑅𝑆 , 𝛼?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) 
≅
𝑃𝑣𝑁
𝑓
1
𝐿
𝜗(1 − 𝜗) + 𝛼2
𝑃𝑣𝑁
𝑓
1
𝐿
𝛾𝐴𝜗(1 − 𝛾𝐴𝜗)
− 2𝛼
𝑃𝑣𝑁
𝑓
1
𝐿
𝛾𝐴𝜗(1 − 𝜗) 
=
𝑃𝑣𝑁
𝑓
1
𝐿
𝜗[(1 − 𝜗)(1 − 2𝛼𝛾𝐴) + 𝛼
2𝛾𝐴(1 − 𝛾𝐴𝜗)]. 
In order to evaluate the anticipated variances and covariances for the estimates derived 
from 𝑆𝐵, we have to preliminarly consider this results: 
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(𝐴10)  𝐸𝑀(𝑦𝑘𝑦𝑗) = Pr(𝑦𝑘 = 1) 𝐸𝑀(𝑦𝑗|𝑦𝑘 = 1) + [1 − Pr(𝑦𝑘 = 0)]0 = 𝜇𝜗  for 𝑘 ∈ 𝑈𝐶 ∩
𝑗 ∈ 𝑈𝑘 ,  
𝑉𝑀(𝑦𝑘𝑦𝑗) = 𝐸𝑀 [(𝑦𝑘𝑦𝑗)
2
] − [𝐸𝑀(𝑦𝑘𝑦𝑗)]
2
= 𝜇𝜗(1 − 𝜇𝜗).                       for 𝑘 ∈ 𝑈𝐶 ∩ 𝑗
∈ 𝑈𝑘 , 
𝑉𝑀[𝑦𝑘𝑦𝑗 (𝐿𝑣𝑗 ≥ 1)] = 𝜇𝜗𝛾𝐵(1 − 𝛾𝐵𝜇𝜗), 
𝐶𝑜𝑣𝑀[𝑦𝑘𝑦𝑗 (𝐿𝑣𝑗 ≥ 1), 𝑦𝑘𝑦𝑗] = 𝜇𝜗𝛾𝐵(1 − 𝜇𝜗). 
Then, we have 
(𝐴11) 𝐴𝑉(?̂?𝐵,𝑆𝑅𝑆) ≅ ∑
1
𝑓
(1−𝑃𝑣)𝑁
𝑘=1
∑
1
(𝐿𝜇)2
 𝑉𝑀(𝑦𝑘𝑦𝑗)
𝐿
𝑗=1:𝑗∈𝑈𝑘
= (1 − 𝑃𝑣)𝑁
1
𝑓𝐿𝜇
𝜗(1 − 𝜇𝜗), 
𝐴𝑉(?̂?𝐴𝐵,𝑆𝑅𝑆
𝐵 ) ≅ (1 − 𝑃𝑣)𝑁
1
𝑓𝐿𝜇
𝜗𝛾𝐵(1 − 𝛾𝐵𝜇𝜗) 
𝐴𝐶𝑜𝑣(?̂?𝐵,𝑆𝑅𝑆 , ?̂?𝐴𝐵,𝑆𝑅𝑆
𝐵 ) ≅ (1 − 𝑃𝑣)𝑁
1
𝑓𝐿𝜇
𝜗𝛾𝐵(1 − 𝜇𝜗). 
Putting together the above results we have: 
(𝐴12)   𝐴𝑉(?̂?𝐵,𝑆𝑅𝑆 − (1 − 𝛼)?̂?𝐴𝐵,𝑆𝑅𝑆
𝐴 ) 
= 𝐴𝑉(?̂?𝐵,𝑆𝑅𝑆) + (1 − 𝛼)
2𝐴𝑉(?̂?𝐴𝐵,𝑆𝑅𝑆
𝐵 ) − 2(1 − 𝛼)𝐴𝐶𝑜𝑣(?̂?𝐵,𝑆𝑅𝑆 , 𝛼?̂?𝐴𝐵,𝑆𝑅𝑆
𝐵 ) 
= (1 − 𝑃𝑣)𝑁
1
𝑓𝐿𝜇
𝜗[(1 − 𝜇𝜗) + (1 − 𝛼)2𝛾𝐵(1 − 𝛾𝐵𝜇𝜗) − 2(1 − 𝛼)𝛾𝐵(1 − 𝜇𝜗)]. 
 
 
 
 
